{"result": "(\"entity\"<|>VIPOMA<|>EVENT<|>VIPoma is a syndrome characterized by severe, intermittent watery diarrhea, hypokalemia, and achlorhydria, often associated with pancreatic tumors secreting vasoactive intestinal peptide (VIP).)\n##\n(\"entity\"<|>RET<|>ORGANIZATION<|>RET is a gene associated with multiple endocrine neoplasia type 2 (MEN2), which can lead to medullary thyroid carcinoma and other conditions.)\n##\n(\"entity\"<|>CANCER MEDULAR DE TIROIDES<|>EVENT<|>Medullary thyroid carcinoma (CMT) is a type of cancer that arises from the parafollicular cells of the thyroid and is associated with mutations in the RET gene.)\n##\n(\"entity\"<|>MEN2B<|>EVENT<|>MEN2B is a genetic syndrome that predisposes individuals to medullary thyroid carcinoma and other tumors, often linked to specific mutations in the RET gene.)\n##\n(\"entity\"<|>SOMATOSTATIN<|>ORGANIZATION<|>Somatostatin is a hormone that inhibits the secretion of several other hormones, including VIP, and is used in the treatment of VIPoma to control diarrhea.)\n##\n(\"entity\"<|>HÍGADO<|>GEO<|>The liver is an organ that can be affected by metastases from malignant tumors, including those associated with VIPoma and medullary thyroid carcinoma.)\n##\n(\"entity\"<|>PÁNCREAS<|>GEO<|>The pancreas is the organ where VIPoma tumors are typically located, particularly in the body or tail of the pancreas.)\n##\n(\"relationship\"<|>VIPOMA<|>CANCER MEDULAR DE TIROIDES<|>VIPoma is associated with the development of medullary thyroid carcinoma due to genetic mutations in RET<|>7)\n##\n(\"relationship\"<|>RET<|>CANCER MEDULAR DE TIROIDES<|>Mutations in the RET gene are linked to the development of medullary thyroid carcinoma<|>8)\n##\n(\"relationship\"<|>MEN2B<|>CANCER MEDULAR DE TIROIDES<|>MEN2B syndrome is associated with a high risk of developing medullary thyroid carcinoma<|>9)\n##\n(\"relationship\"<|>VIPOMA<|>SOMATOSTATIN<|>Somatostatin is used as a treatment to control the symptoms of VIPoma<|>6)\n##\n(\"relationship\"<|>CANCER MEDULAR DE TIROIDES<|>HÍGADO<|>Medullary thyroid carcinoma can lead to metastases in the liver<|>5)\n##\n(\"relationship\"<|>VIPOMA<|>PÁNCREAS<|>VIPoma tumors are typically located in the pancreas<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: el síndrome del vipoma debido a la se-                                                     cogén RET (genotipo) y la edad de inicio y agresividad del cáncer medular de tiroides (CMT),\n         creción del VIP; se denomina también cólera pancreática, síndrome de Verner-Morrison                                                     y la presencia o ausencia de feocromocitoma [o HPP (fenotipo)]. El feocromocitoma es más\n         o   síndrome     de   diarrea    acuosa,    hipopotasemia        y  aclorhidria    (WDHA,     watery     diarrhea,                       frecuente en pacientes con mutaciones RET en el exón 11 (particularmente codón 634), y\n         hypokalemia, achlorhydria). Se caracteriza por diarrea acuosa, grave, intermitente, con un                                               ocurre raramente en pacientes con mutaciones en el exón 8 (codón 533), exón 10 (codones\n         alto contenido de potasio, bicarbonato y cloruro, lo que ocasiona acidosis metabólica. Esta                                              609, 611, 618, 620), exón 13 (codones 768, 790, 791 y 804), y exón 15 (codón 891). Existe una\n         diarrea persiste durante el ayuno y es de alto volumen (>700 ml/día). Los pacientes pue-                                                 fuerte asociación entre HPP y mutaciones en el codón 634.\n         den presentar signos y síntomas de hipopotasemia, acidosis metabólica y deshidratación.                                                  El 95% de los pacientes con MEN2B tienen la mutación Met918Thr (M918T) en el exón 16;\n         Aproximadamente en el 15% de los pacientes se observa un enrojecimiento cutáneo en la                                                    también se ha descrito la mutación Ala883Phe (A883F) en el exón 15 (2-3%), que origina un\n         cabeza y el tronco, generalmente durante los episodios de diarrea, que puede ir asociado a                                               CMT menos agresivo que la mutación M918T. Raramente se han descrito pacientes MEN2B\n         un exantema eritematoso difuso.                                                                                                          con las mutaciones en tándem: V804M + E805K, V804M + Y806C y V804M + S904C, que se\n         El tratamiento inicial de los pacientes con síndrome del vipoma consiste en el reemplazo                                                 caracterizan por un inicio más tardío del CMT y agresividad variable.\n         agresivo de líquidos y electrolitos. Para controlar la diarrea, el tratamiento de elección son                                           La misma mutación puede ocasionar diferentes manifestaciones clínicas y distinta pene-\n         los análogos de la somatostatina, que inhiben la secreción de VIP, reducen la concentra-                                                 trancia y agresividad del CMT en la misma familia o en diferentes familias; esto sugiere\n         ción circulante e inhiben directamente las secreciones intestinales.                                                                     que otros cambios genéticos u otros modificadores genéticos son responsables de estas\n         El tratamiento definitivo requiere la extirpación quirúrgica del tumor, que suele estar loca-                                            diferencias fenotípicas.\n         lizado en el cuerpo o en la cola del páncreas. Aunque los tumores suelen ser solitarios, un                                              Esta correlación genotipo-fenotipo se ha utilizado para realizar recomendaciones respecto\n         60% de ellos son malignos en el momento del diagnóstico, el 75% da lugar a metástasis en                                                 a la edad para realizar una tiroidectomía total profiláctica y comenzar el cribado bioquímico\n         el hígado y en los ganglios linfáticos regionales, pero también pueden aparecer metástasis                                               para feocromocitoma e hiperparatiroidismo.\n         en pulmón y hueso (opción D falsa: respuesta correcta).                                                                                  En los   portadores genéticos de mutación RET                  asintomáticos existe consenso sobre la\n         Referencias:                                                                                                                             necesidad de realizar una tiroidectomía total profiláctica, pero no sobre la edad en que se\n         • Bergsland E. VIPoma: Clinical manifestations, diagnosis and management. Tanabe KK, ed. UptoDate. Waltham, MA: UpToDate Inc.            debe realizar; para algunos autores debería hacerse antes del desarrollo del CMT, y para\n           https://www.uptodate.com (acceso 13 de junio de 2019).\n         • Melmed S, Polonsky KS, Reed Larsen P, Kronenberg HM. Williams Textbook of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016.        otros, antes de la extensión del CMT fuera de la glándula, lo que garantizaría en ambas\n                                                                                                                                                  situaciones su curación a largo plazo.\n\n\n\n404                                                                                                                                                                                                                                                         405\n---\n                                                                                                                                                                    METABOLISMO FOSFOCÁLCICO,                                           TUMORES\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}